EUVIMEDEUVIMED entdecken
Crossref

Patient and Provider Knowledge and Attitudes Regarding Vaccination with the 9-Valent HPV Vaccine during Pregnancy

Sarah Boudova iD, Meghan Gannon, Jennifer Zhan, Valentina Frusone, Aichatou Haidara, Agustina Arce, Kelly McGuigan, Beth I Schwartz, Christopher Chambers, Rupsa C Boelig iD

American Journal of Perinatology · 21.08.2026

DOI: 10.1055/a-2936-5812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 21.08.2026. Verfasst von Sarah Boudova und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Illinois Chicago, Department of Obstetrics and Gynecology, Illinois, United States, Chicago. Gefördert von: UIC Building Interdisciplinary Research Careers in Women's Health (BIRCWH)from the National Institutes of Health (NIH) Office of Research on Women's Health (OR….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cervical cancer is preventable with the human papillomavirus (HPV) vaccine; however, vaccination rates remain low. Pregnancy presents an opportunity to complete vaccination. Preliminary safety data are reassuring, but vaccination is currently contraindicated in pregnancy. We aimed to examine patient and provider knowledge and attitudes regarding 9-valent HPV vaccination in pregnancy. Study Design We performed a mixed-methods study utilizing patient focus group discussions (FGDs) and a national provider survey. FGDs with pregnant patients were conducted until thematic saturation was achieved. Surveys were sent to providers from the American College of Obstetricians and Gynecologists (ACOG) mailing list until the sample size (300) was achieved. Thematic analysis and descriptive statistics were performed on FGD transcripts and survey results. Findings were integrated and interpreted together.

Results

We recruited 18 FGD patient participants and analyzed 321 provider surveys. Five key themes emerged from the integrated data: (1) knowledge of the HPV vaccine in pregnancy, (2) perceptions of HPV vaccine safety, (3) perceptions of HPV vaccine efficacy, (4) vaccine decision-making process, and (5) barriers and facilitators of HPV vaccination in pregnancy. Patient participant knowledge of the vaccine was variable. Physician recommendation and personal autonomy were key factors in their patient participants' vaccine decision-making. Patient and provider participants expressed uncertainty about the safety and efficacy of the vaccine in pregnancy. A primary concern was fetal well-being. Both desired more research on vaccine safety and efficacy. Main provider-identified barriers to vaccination during pregnancy were professional organization recommendations against vaccination, safety concerns during pregnancy, and patient vaccine hesitancy. Most provider participants would offer vaccination during pregnancy if not contraindicated.

Conclusion

Patients and providers report significant uncertainty about the safety and efficacy of the HPV vaccine in pregnancy. More research and permissive language from professional organizations are needed before patients and providers would feel comfortable with antepartum vaccination. Key Points Provider recommendation is the key in vaccine decisions. There is uncertainty about the safety of the HPV vaccine in pregnancy. There is uncertainty about the efficacy of the HPV vaccine in pregnancy. More research is desired on HPV vaccine in pregnancy. Providers adhere to professional vaccine guidelines.

Autor:innen und Institutionen

  • University of Illinois Chicago, Department of Obstetrics and Gynecology, Illinois, United States, Chicago.
  • College of Nursing, Thomas Jefferson University, Department of Obstetrics and Gynecology, Pennsylvania, United States, Philadelphia.
  • Sidney Kimmel Medical College, Thomas Jefferson University, Pennsylvania, United States, Philadelphia.
  • Thomas Jefferson University, Department of Obstetrics and Gynecology, Pennsylvania, United States, Philadelphia.
  • Thomas Jefferson University, Department of Family Medicine, Pennsylvania, United States, Philadelphia.

ORCID-Profile: Sarah Boudova, Rupsa C Boelig

Förderung

  • UIC Building Interdisciplinary Research Careers in Women's Health (BIRCWH)from the National Institutes of Health (NIH) Office of Research on Women's Health (OR…

Zitieren

APA

Boudova, S., Gannon, M., Zhan, J., Frusone, V., Haidara, A., Arce, A., McGuigan, K., Schwartz, B. I., Chambers, C., & Boelig, R. C. (2026). Patient and Provider Knowledge and Attitudes Regarding Vaccination with the 9-Valent HPV Vaccine during Pregnancy. American Journal of Perinatology. https://doi.org/10.1055/a-2936-5812

Vancouver

Boudova S, Gannon M, Zhan J, Frusone V, Haidara A, Arce A, et al. Patient and Provider Knowledge and Attitudes Regarding Vaccination with the 9-Valent HPV Vaccine during Pregnancy. American Journal of Perinatology. 2026. doi:10.1055/a-2936-5812

BibTeX
@article{Boudova2026,
  author = {Boudova, Sarah and Gannon, Meghan and Zhan, Jennifer and Frusone, Valentina and Haidara, Aichatou and Arce, Agustina and McGuigan, Kelly and Schwartz, Beth I and Chambers, Christopher and Boelig, Rupsa C},
  title = {Patient and Provider Knowledge and Attitudes Regarding Vaccination with the 9-Valent HPV Vaccine during Pregnancy},
  journal = {American Journal of Perinatology},
  year = {2026},
  doi = {10.1055/a-2936-5812}
}
Kostenlos starten →